Introduction
============

Neonatal seizures represent a heterogeneous group of clinical pediatric epileptology. While prolonged or recurrent developmental seizures may induce long-term neurobehavioral, cognitive and pathological sequelae ([@b1-mmr-16-04-4701],[@b2-mmr-16-04-4701]), neonatal hypocalcemic or hypoglycemic seizures in the first week of life, on the other hand, may be benign. Furthermore, neonatal seizures may be refractory to antiepileptic drugs such as phenobarbital, which has exhibited long-term cognitive and intellectual impairment for febrile seizures ([@b3-mmr-16-04-4701]). Therefore, an improved understanding of the molecular mechanisms of altered brain maturation and function following neonatal seizures is required before age-appropriate treatments can be optimized.

The hippocampus is more vulnerable to epileptic insults compared with the cerebral cortex. Hippocampal sclerosis is a neuropathological condition that may be observed in mesial temporal lobe epilepsy (MTLE) and other epilepsy syndromes, which may be identified in surgery or post-mortem ([@b4-mmr-16-04-4701]). Permanent hippocampal changes that develop over weeks include circuit organization, which may be identified by aberrant mossy fiber sprouting and functional properties in adult hippocampal circuitry, and may influence epileptogenesis ([@b5-mmr-16-04-4701]). In fact, aberrant sprouting of hippocampal mossy fibers has been recognized as a pathological hallmark of MTLE ([@b6-mmr-16-04-4701]).

Recently, abnormal zinc (Zn) metabolism has been reported to be associated with hippocampal mossy fiber sprouting. Zn deficiency or excess Zn contributes to impaired behavior and brain developmental disorders ([@b7-mmr-16-04-4701]). Brain Zn is abundantly distributed in the Zn-rich mossy fiber pathway in the hippocampus, which is important in maintaining a balance between excitatory and inhibitory systems, particularly in the pathological process of epileptogenesis following an initial brain-damaging insult ([@b8-mmr-16-04-4701]). Zn transporters have an important role in the deleterious changes of axon sprouting. We previously reported long-term downregulated expression of Zn transporter (ZnT)-1 and upregulated expression of ZnT-3 in the rat hippocampus following volatile flurothyl-induced neonatal or penicillin-induced developmental seizures, which is in parallel with increased regenerative hippocampal mossy fiber sprouting ([@b9-mmr-16-04-4701]--[@b11-mmr-16-04-4701]). However, we did not determine the expression pattern of other Zn transporters.

We previously reported altered expression of various lipid metabolism-associated genes in the hippocampus following neonatal seizures, including apolipoprotein J, apolipoprotein E, acetyl-CoA acetyltransferase 1 and plasticity-related genes (PRGs) ([@b12-mmr-16-04-4701]). Using an identical neonatal seizure model, we recently demonstrated significant upregulated expression of ZnT-3, metallothionein-3 (MT-3) and lipid metabolism-associated apolipoprotein E, clusterin and acetyl-CoA acetyltransferase 1 in the hippocampus, and also reported that a ketogenic diet blocked these effects ([@b13-mmr-16-04-4701]). Therefore, we hypothesized that an interaction between Zn and lipid metabolism signals may exist in the experimental neonatal seizure model.

The aim of the present study was to investigate the long-term expression of Zn transporter and lipid metabolism-associated genes following neonatal seizures. Unlike in our previous studies, the present study evaluated the gene expression in early adulthood on postnatal day 35 (P35; 21 days after the last neonatal seizure). In addition, the current study compared the expression of Zn transporters with lipid metabolism-associated gene expression. Furthermore, the hippocampus and cerebral cortex were analyzed as it has been reported that status epilepticus in the immature rat induced neuronal degeneration in multiple regions outside the hippocampus ([@b14-mmr-16-04-4701]), and also because pediatric cortical dysplasia may also have key roles in epileptogenesis ([@b15-mmr-16-04-4701]).

Materials and methods
=====================

### Animal preparation

Sprague-Dawley rats with balanced sex distribution (weight, 11--13 g; supplied by Shanghai SLAC Laboratory Animal Co., Ltd., Shanghai, China) were treated in accordance with the guidelines set by the National Institutes of Health (Bethesda, MD, USA) for the humane treatment of animals. Ethical approval was obtained from the Medical Ethics Committee of the Children\'s Hospital of Soochow University. Rats (n=24) at postnatal day 6 (P6) were assigned to the following two groups: Recurrent-seizures (RS) group (n=12); and control group (n=12). The procedure of seizure induction has been described in detail previously ([@b16-mmr-16-04-4701]). In brief, neonatal rats were placed into a transparent plastic airtight box and liquid volatile flurothyl (bis-2, 2, 2-triflurothyl ether; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) was delivered through a syringe. The experimental rats were subjected to forty-five induced seizures during nine consecutive days, between P6 and P14. Rats had five seizures per day for nine consecutive days, with a minimum of 30 min between seizures. Control rats were placed into the container for an equal amount of time without exposure to flurothyl. The litters were weaned on postnatal day 21, and following this age they were housed in an environment-controlled room which was away from bright light and noise (temperature 22±1°C; humidity 70±5%) under a 12/12 h standard light-dark cycle and had access to standard laboratory food and water *ad libitum*. Animals were sacrificed by decapitation at P35 for Timm staining and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) experiments.

### Timm staining

Six rats from each group were anesthetized intraperitoneally with 4% chloral hydrate (1 ml/100 g; Sangon Biotech Co., Ltd., Shanghai, China). The method has been described in detail previously ([@b9-mmr-16-04-4701]).

### RT-qPCR

This method has been described in detail previously ([@b10-mmr-16-04-4701]). The primers and Taqman probes of the twenty genes were designed based on GenBank-published sequences with the software Primer Express 2.0 (Applied Biosystems; Thermo Fisher Scientific, Inc., Waltham, MA, USA), the sequences of which are listed in [Table I](#tI-mmr-16-04-4701){ref-type="table"}. Thermocycling conditions for qPCR (Applied Biosystems 7500 Real-Time PCR System; Thermo Fisher Scientific, Inc.): 40 cycles (95°C, 15 sec for denaturation; 60°C, 1 min for annealing/extension). The experiment was repeated two times. The 2^−ΔΔCq^ method of relative quantification was used to determine the fold change in expression. Initially, the qPCR threshold cycle (Cq) of the target mRNAs and the internal control β-actin was determined. Subsequently, the ratios of target genes: β-actin were calculated as follows: Target gene:β-actin=2^Cq(target)-Cq(β−actin)^(ΔCq=Cq target-Cq β-actin) ([@b17-mmr-16-04-4701]). The fold change in expression was then obtained.

### Statistical analysis

Statistical analysis of the changes in gene expression levels (2^−ΔΔCq^) was performed using one-way analysis of variance followed by Dunnett\'s test. Linear correlations were analyzed by Pearson correlation analysis. SAS 8.0 statistical software (SAS Institute, Cary, NC, USA) was used to perform statistical analysis. Data are presented as the mean + standard deviation. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Timm staining

No obvious mossy fiber terminals in the control hippocampus ([Fig. 1A](#f1-mmr-16-04-4701){ref-type="fig"}) were observed. However, prominent aggregation of mossy fiber terminals was observed in the supragranular region of the dentate gyrus and CA3 subfield in the RS group ([Fig. 1B](#f1-mmr-16-04-4701){ref-type="fig"}).

### RT-qPCR analysis

RT-qPCR was performed to investigate changes in the relative gene expression of Zn transporter (ZnT) 1--7, Zrt/Irt-like protein (Zip)-6, Zip-7 and solute carrier family 41 member 1, which are involved in Zn transport, growth hormone (Gh), nuclear receptor subfamily 3 group C member 1 (Nr3c1, glucocorticoid receptor), ATP binding cassette subfamily C member 8 (Abcc8) and neuropeptide Y (Npy), which are involved in the regulation of lipid and energy metabolism, as well as glutamate ionotropic receptor AMPA type subunit 1 (GluR1) and 2 (GluR2), PRG-3, annexin A7 (ANX7), ANX3 and Bcl-2, which are involved in the regulation of neuroexcitability and neuroprotection. Of the twenty genes investigated, seven (ZnT-1, ZnT-2, Gh, Nr3c1, Abcc8, Npy and Bcl-2) were significantly downregulated, while four (ZnT-3, Zip-6, Zip-7 and PRG-3) were significantly upregulated in the RS group compared with CONT rats, which was only observed in the hippocampus ([Figs. 2](#f2-mmr-16-04-4701){ref-type="fig"}--[4](#f4-mmr-16-04-4701){ref-type="fig"}). No significant differences in gene expression were observed in the cerebral cortex between the two groups.

Linear correlation analysis among the eleven genes with significantly altered expression patterns (ZnT-1, ZnT-2, Gh, Nr3c1, Abcc8, Npy, Bcl-2, ZnT-3, Zip-6, Zip-7 and PRG-3) demonstrated that twenty-two different gene pairs exhibited significant positive or negative correlations, which accounted for 40% of the total of fifty-five gene pair combinations in the hippocampus ([Fig. 5](#f5-mmr-16-04-4701){ref-type="fig"}). The gene pairs that exhibited significant correlations in expression are as follows: Five pairs of genes among Zn transporters (r~ZnT-1/ZnT-2~=0.59, P\<0.05; r~ZnT-3/ZnT-2~=−0.62, P\<0.05; r~Zip-6/ZnT-3~=0.96, P\<0.0001; r~Zip-7/ZnT-3~=0.9, P\<0.0001; r~Zip-7/Zip-6~=0.93, P\<0.0001); eight pairs of genes among metabolism-associated genes (r~Npy/Abcc8~=0.74, P\<0.001; r~Bcl-2/Gh~=0.81, P\<0.01; r~Npy/Gh~=0.63, P\<0.05; r~Nr3c1/Gh~=0.85, P\<0.001; r~Bcl-2/PRG-3~=−0.86, P\<0.001; r~PRG-3/Gh~=−0.596, P\<0.05; r~Bcl-2/Npy~=0.64, P\<0.05; r~PRG-3/Npy~=−0.69, P\<0.05); and nine pairs of genes between Zn transporter and metabolism-associated genes (r~ZnT-1/Gh~=0.58, P\<0.05; r~ZnT-2/Gh~=0.89, P\<0.001; r~ZnT-3/Gh~=−0.67, P\<0.05; r~Bcl-2/ZnT-1=~0.75, P\<0.01; r~Npy/ZnT-1=~0.72, P\<0.01; r~PRG-3/ZnT-1=~-0.82, P\<0.01; r~Nr3c1/ZnT-2=~0.69, P\<0.05; r~PRG-3/ZnT-2=~-0.75, P\<0.01). Notably, the r values of twelve gene pairs in the hippocampus were \>0.7 with P\<0.01. Of these twelve pairs, eight pairs were between Zn transporter and metabolism-associated genes or among Zn transporter genes ([Fig. 5A](#f5-mmr-16-04-4701){ref-type="fig"}), while four pairs were among metabolism-associated genes ([Fig. 5B](#f5-mmr-16-04-4701){ref-type="fig"}). Notably, Gh exhibited significant correlations with seven of the other genes that were analyzed (ZnT-1-ZnT-3, Nr3c1, Npy, PRG-3 and Bcl-2.). In addition, Gh also exhibited correlations with another three genes (r~Zip6/Gh=~-0.56, P=0.056; r~Zip7/Gh=~-0.55, P=0.064; r~Abcc8/Gh=~0.56, P=0.06), although these were not significant. Specifically, PRG-3 was significantly negatively correlated with Gh, Npy, Bcl-2, ZnT-1 and ZnT-2. However, only eight pairs of genes in the cerebral cortex exhibited significant positive correlations, which accounted for 14.5% of the total fifty-five gene pair combinations ([Fig. 6](#f6-mmr-16-04-4701){ref-type="fig"}).

Discussion
==========

The present study demonstrated that flurothyl-treated rats exhibited aberrant mossy fiber sprouting in the hippocampus, as well as downregulated ZnT-1 and upregulated ZnT-3 expression. These results are consistent with our previous studies using flurothyl or penicillin-induced developmental seizure rat models ([@b9-mmr-16-04-4701],[@b10-mmr-16-04-4701]). Unlike our previous work, however, the results of the present study also indicated downregulated ZnT-2 and upregulated Zip-6/7 expression in the hippocampus. It has been previously reported that ZnT-1 and ZnT-3 are involved in Zn transport out of or into synaptic vesicles in the mossy fiber boutons, respectively, while ZnT-2 may prevent Zn causing toxicity in neurons by facilitating the movement of Zn into endosomes and lysosomes ([@b18-mmr-16-04-4701],[@b19-mmr-16-04-4701]). In addition, Zip proteins are involved in the transport of Zn from the extracellular space into the cytoplasm. Although the expression of Zip transporters (Zip-6 and Zip-7) has been reported in the brain ([@b20-mmr-16-04-4701],[@b21-mmr-16-04-4701]), to the best of our knowledge, their expression following developmental seizures has not previously been investigated. Therefore, the present study demonstrated for the first time that the expression of Zip-6/7 was altered at the transcriptional level in the hippocampus at a long-term time point following neonatal seizures, which may also be implicated in the intracellular Zn dyshomeostasis and pathophysiology of mossy fiber sprouting in the hippocampus.

Furthermore, the present study reported downregulated expressions of four lipid metabolism-associated genes. It is established that Gh is involved in the regulation of lipid metabolism ([@b22-mmr-16-04-4701]). Disturbed expression of Gh in the hippocampus was reported to be associated with epilepsy progression in a model of TLE ([@b23-mmr-16-04-4701]). Npy, an orexigenic hormone, is also involved in energy and lipid regulation and may act as a neuroprotective agent in the hippocampus during epileptic activities ([@b24-mmr-16-04-4701],[@b25-mmr-16-04-4701]). Cortisol binding to glucocorticoid receptors (Nr3c1) modulates lipid metabolism via glucocorticoid regulation. Glucocorticoids in the hippocampus have been reported to exhibit important roles in neuronal plasticity, electrical activity and cognitive functions ([@b26-mmr-16-04-4701]). Abcc8 is one of the subunits of the ATP-sensitive potassium (K~ATP~) channel that connects energy metabolism to electrical excitability. It has recently been reported that Nr3c1 and Abcc8 mRNA levels in the hippocampus were significantly downregulated at 10 days or 2 months post status epilepticus in adult rats in the pilocarpine model of TLE ([@b27-mmr-16-04-4701]). Consistent with these previous studies, the present results demonstrated decreased mRNA levels of the four lipid metabolism-associated genes at 21 days post the last neonatal seizure attacks. These results indicate that lipid metabolism-associated molecules, in addition to Zn transporters, may be associated with pathological changes in the hippocampus following developmental seizures. Although there is no direct evidence regarding the interaction between Zn and lipid metabolism pathways during epileptogenesis, recent progress concerning PRGs may provide valuable insight.

PRGs are a subclass of the lipid phosphate phosphatase (LPP) superfamily. Unlike traditional LPPs, PRGs are predominantly expressed in the central nervous system, and may modify bioactive lipids and the associated signaling pathways to exert their function ([@b28-mmr-16-04-4701]). For example, PRG-1 functions as an ectoenzyme and was reported to prevent phospholipid-induced axon collapse in neurons and enhance hippocampal outgrowth ([@b29-mmr-16-04-4701],[@b30-mmr-16-04-4701]). Previously, using a semi-quantitative RT-PCR method, we investigated the dynamic pattern of the gene expression of ZnT-1, ZnT-3 and PRG-1 in the rat brain following flurothyl-induced prolonged neonatal seizures at 1.5, 3, 6, 12, 24 and 48 h, and 7 and 14 days after the last induced seizure. The results demonstrated that long-term, 14 days after the last seizure, ZnT-3 mRNA and PRG-1 protein levels in the hippocampus were upregulated, while downregulated mRNA expression of ZnT-1 was observed ([@b11-mmr-16-04-4701]). These results are consistent with the results of the current study. The present study also reported a similar decrease in ZnT-1, and upregulated ZnT-3 and PRG-3 expression in the hippocampus at 21 days after the last seizure, and sprouting of hippocampal mossy fibers was also observed. Linear correlation analysis further demonstrated that PRG-3 was significantly negatively correlated with Gh, Npy, Bcl-2, ZnT-1 and ZnT-2. In addition, a further seven pairs of genes between Zn transporter and lipid metabolism-associated molecules exhibited significant positive correlations. These results may support the results of a study by Blanco-Alvarez *et al* ([@b31-mmr-16-04-4701]), which reported an increase of Zn and lipoperoxidation levels, cell death by necrosis and apoptosis in the late phase of ischemia in the rat temporoparietal cortex and hippocampus when pretreated with Zn and receiving L-NAME administration 1 h prior to common carotid-artery occlusion, indicating a synergistic relationship between Zn and lipid metabolism signals during brain injury. Therefore, it may be hypothesized a synergistic interaction exists between Zn and lipid metabolism pathways during epileptogenesis, which requires further investigation.

In addition, the present study demonstrated a potential increase in hippocampal apoptosis as evidenced by the downregulated expression of Bcl-2 in the hippocampus in flurothyl-treated rats. Bcl-2 is an apoptosis suppressor and it has been reported that downregulated Bcl-2 expression contributes to apoptotic cell death during acute brain damage following experimental seizures ([@b32-mmr-16-04-4701],[@b33-mmr-16-04-4701]). However, it is not clear whether developmental seizure attacks lead to long-term disturbance of apoptosis-associated signaling pathways during adulthood. In the current study, decreased mRNA levels of Bcl-2 in the hippocampus were observed at the long-term time point after seizures. Due to the lack of the results regarding other apoptosis-associated molecules, our observations only indicate a potential disrupted apoptosis-associated signal at the mRNA level. The long-term effects of developmental seizures on apoptosis in the hippocampus requires investigation in future experimental studies.

The current study has certain limitations. For example, the present study did not investigate the cell types in the hippocampus that contributed to the changes in gene expression. However, previous studies have demonstrated that Gh, Npy, PRG-3 and ZnT-3 are synthesized by hippocampal neurons, where their expression is affected by exposure to stress ([@b34-mmr-16-04-4701]--[@b40-mmr-16-04-4701]). The results of the current study demonstrated significantly up or downregulated expression of these four genes accompanied by strong correlations in expression following seizures. These results indicate that the cell type responsible for the observed results in the present study may be neurons. However, as immunohistochemistry or *in situ* hybridization studies were not performed in the present study, other cell types, including astrocytes or microglia, may also be involved in the expression of the regulated genes, which also requires further investigation.

In conclusion, the current study demonstrated, for the first time, based on molecular evidence, that altered expression of Zn transporter and metabolism-associated genes may be associated with neonatal seizure-induced aberrant mossy fiber sprouting in the hippocampus, and may be potential targets for the treatment of neonatal seizure-induced brain injury.
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![Mossy fiber sprouting by Timm staining in (A) CONT and (B) RS groups. Timm staining was used to investigate mossy fiber sprouting in the dentate gyrus and CA3 subfield of the hippocampus of rats in CONT and RS groups. Notably, excessive Timm staining was observed in the inner molecular layer of the granule cells in the dentate gyrus (arrow) and the stratum pyramidale of the CA3 subfield (arrowhead) in the RS group. CONT, control; RS, recurrent seizures; CA3, Cornu Ammonis 3.](MMR-16-04-4701-g00){#f1-mmr-16-04-4701}

![Reverse transcription-quantitative polymerase chain reaction analysis of Zn transporter-associated genes. When comparing mRNA levels between control and recurrent seizure groups, ZnT-1, ZnT-2, ZnT-3, Zip-6 and Zip-7 exhibited significant differences in the hippocampus. \*P\<0.05 vs. control. Zn, zinc; ZnT, Zn transporter; Zip, Zrt/Irt-like protein; DCT-1, solute carrier family 41 member 1.](MMR-16-04-4701-g01){#f2-mmr-16-04-4701}

![Reverse transcription-quantitative polymerase chain reaction analysis of lipid and energy metabolism-associated genes. When comparing mRNA levels between control and recurrent seizure groups, Gh, Nr3c1, Abcc8 and Npy exhibited significant differences in the hippocampus. \*P\<0.05 vs. control. Gh, growth hormone; Nr3c1, nuclear receptor subfamily 3 group C member 1; Abcc8, ATP binding cassette subfamily C member 8; Npy, neuropeptide Y.](MMR-16-04-4701-g02){#f3-mmr-16-04-4701}

![Reverse transcription-quantitative polymerase chain reaction analysis of neuroexcitability and neuroprotection-associated genes. When comparing mRNA levels between control and recurrent seizure groups, PRG-3 and Bcl-2 exhibited significant differences in the hippocampus. \*P\<0.05 vs. control. PRG, plasticity-related gene; GluR1, glutamate ionotropic receptor AMPA type subunit 1; GluR2, glutamate ionotropic receptor AMPA type subunit 2; ANX7, annexin A7; ANX3, annexin A3.](MMR-16-04-4701-g03){#f4-mmr-16-04-4701}

![Linear correlation analysis of reverse transcription-quantitative polymerase chain reaction results in the hippocampus. (A) The r-values of eight gene pairs were \>0.7 with P\<0.01, and the majority of these gene pairs consisted of a zinc transporter and a metabolism-associated gene. (B) Upper, the r-values of four gene pairs were \>0.7 with P\<0.01, with pairs consisting of metabolism-associated genes and neuroexcitability/neuroprotection-associated genes. Lower, significant positive correlations (P\<0.05) were observed for twenty-two gene pairs, which accounted for 40% of the total fifty-five gene pair combinations. Npy, neuropeptide Y; ZnT, zinc transporter; PRG, plasticity-related gene; Gh, growth hormone; Zip, Zrt/Irt-like protein; Nr3c1, nuclear receptor subfamily 3 group C member 1; Abcc8, ATP binding cassette subfamily C member 8.](MMR-16-04-4701-g04){#f5-mmr-16-04-4701}

![Linear correlation analysis of reverse transcription-quantitative polymerase chain reaction results in the cerebral cortex. Only eight pairs of genes exhibited significant positive correlations, which accounted for 14.5% of the total fifty-five gene pair combinations. Npy, neuropeptide Y; Abcc8, ATP binding cassette subfamily C member 8; Zip, Zrt/Irt-like protein; Gh, growth hormone; ZnT, zinc transporter.](MMR-16-04-4701-g05){#f6-mmr-16-04-4701}

###### 

Oligonucleotide primers and probes for reverse transcription-quantitative polymerase chain reaction analysis.

  Gene      GenBank accession number   Primer sequence                     Probe sequence
  --------- -------------------------- ----------------------------------- -----------------------------------------------
  β-actin     NM_031144                F: 5′-TTGCTGACAGGATGCAGAAGGAGA-3′   5′-FAM-AAGTACATTGCTCCTCCTGAGCGCAA-TAMRA-3′
                                       R: 5′-ACTCCTGCTTGCTGATCCACATCT-3′   
  ZnT-1     NM_022853                  F: 5′-CGTTGTTGTGAATGCCTTGGT-3′      5′-FAM-TTCTACTTTTCCTGGAAGGGTTGTA-TAMRA-3′
                                       R: 5′-GGGTTCACACAAAAGTCGTCTTC-3′    
  ZnT-2     RNU50927                   F: 5′-GGCTGGATCCTGGACTAATGTT-3′     5′-FAM-CTCACACCACAGCTGGAGAGACACTGAGG-TAMRA-3′
                                       R: 5′-ACACCCCAAAATCCCTTTCTG-3′      
  ZnT-3     NM_001013243               F: 5′-TGGGCGCTGACGCTTACT-3′         5′-FAM-ACCACGTTGCCTCCGCACACCT-TAMRA-3′
                                       R: 5′-GTCAGCCGTGGAGTCAATAGC-3′      
  ZnT-4     NM_172066.1                F: 5′-GCTGAAGCAGAGGAAGGTGAA-3′      5′-FAM-CAGGCTGACCATCGCTGCCGT-TAMRA-3′
                                       R: 5′-TCTCCGATCATGAAAAGCAAGTAG-3′   
  ZnT-5     NM_001106404.1             F: 5′-CCAGCACATGTCTGGCCTAA-3′       5′-FAM-CACTGGCTTCCACGATGTCCTGGCTAT-TAMRA-3′
                                       R: 5′-TTTGCAGTACTTCATGGATTCCA-3′    
  ZnT-6     NM_001106708.1             F: 5′-CGGCATTATCCCAGGACTCA-3′       5′-FAM-TTCTTGCCCCGCATGAACCCG-TAMRA-3′
                                       R: 5′-CCAGCAAGATCGATCAGAACAA-3′     
  ZnT-7     XM_001073594.1             F: 5′-TTGGGATCCGCGTCTGA-3′          5′-FAM-TCGTCTCTGCTGTCACTGCCGCC-TAMRA-3′
                                       R: 5′-CCCTCTAGAAGTGACTCGGTATGG-3′   
  DCT-1     NM_001108855.1             F: 5′-TGGCTGCCTCAGCATCTG-3′         5′-FAM-AAAACCAGAGCCCCTTCCCTACGCA-TAMRA-3′
                                       R: 5′-CCCAGTTGTTGAGTGGTTTGG-3′      
  Zip-6     NM_001024745.1             F: 5′-CTCACTGCTGGCTTGTTCATG-3′      5′-FAM-TCGCTCTGGTCGACATGGTACCCG-TAMRA-3′
                                       R: 5′-CGTGATCACTGGCATCATTGT-3′      
  Zip-7     NM_001008885.1             F: 5′-GACTTGGCACACAACTTCACAGA-3′    5′-FAM-CTGGCCATTGGTGCTTCCTTCCG-TAMRA-3′
                                       R: 5′-GGACTGTCATCGTGGTCAGGAT-3′     
  Gh        NM_001034848               F: 5′-GCTGCTCTCCTGCTTCAAGAA-3′      5′-FAM-ACCTGCACAAGGCAGAGACCTACCTGC-TAMRA-3′
                                       R: 5′-AGCGGCGACACTTCATGAC-3′        
  Nr3c1     NM_012576                  F: 5′-GGGAGGAGCTACAGTCAAGGTTT-3′    5′-FAM-CATCTTCGCCCTCAGTGGCTGCTG-TAMRA-3′
                                       R: 5′-GCCTTTCGAGAAATCAAGGAGAA-3′    
  Abcc8     NM_013039                  F: 5′-ATCTCCCCAGGACAGAAGATTG-3′     5′-FAM-CCGCACAGGCAGTGGAAAATCCTC-TAMRA-3′
                                       R: 5′-CGGAAAAAGGCGAGAGAGAA-3′       
  Npy       NM_012614                  F: 5′-TCTGCCTGTCCCACCAATG-3′        5′-FAM-TGCCACCACCAGGCTGGATTCC-TAMRA-3′
                                       R: 5′-CAACGACAACAAGGGAAATGG-3′      
  GluR1     NM_031608                  F: 5′-GGCGCCGGACCAATTAC-3′          5′-FAM-CCCTCCACGTGATCGAAAT
                                       R: 5′- CCAATCTTTCGGATTCCATCA-3′     GAAAC-TAMRA-3′
  GluR2     NM_017261                  F: 5′-CCAAGGACTCGGGAAGTAAGG-3′      5′-FAM-AAAGACCAGTGCCCTCA GTCTGAGC-TAMRA-3′
                                       R: 5′-CCCCCGACAAGGATGTAGAA-3′       
  PRG-3     NM_201271                  F: 5′-CGTGATTGCCGGCTTCA-3′          5′-FAM-CCTGGGCACCGCAGTAGCCC-TAMRA-3′
                                       R: 5′-CCACACACATGCCCAAAAAC-3′       
  ANX7      NM_130416                  F: 5′-TTGTGGATGTCGTGTCTA-3′         5′-FAM-CGTTCCAATGACCAGAGGCA-TAMRA-3′
                                       R: 5′-GGCATCATAGTATGTAGGAG-3′       
  ANX3      NM_012823                  F: 5′-CCTGCTGCTGGCCGTAGT-3′         5′-FAM-CGCTGTACGAGGAACACCCCAGCT-TAMRA-3′
                                       R: 5′-TGATGAAGTCTTCCTGCCAAAA-3′     
  Bcl-2     NM_016993                  F: 5′-CTGGGATGCCTTTGTGGAA-3′        5′-FAM-CCCCAGCATGCGACCTCTGTTTG- TAMRA-3′
                                       R: 5′-TGAGCAGCGTCTTCAGAGACA-3′      

ZnT, zinc transporter; DCT-1, solute carrier family 41 member 1; Zip, Zrt/Irt-like protein; Gh, growth hormone; Nr3c1, nuclear receptor subfamily 3 group C member 1; Abcc8, ATP binding cassette subfamily C member 8; Npy, neuropeptide Y; GluR1, glutamate ionotropic receptor AMPA type subunit 1; GluR2, glutamate ionotropic receptor AMPA type subunit 2; PRG, plasticity-related gene 3; ANX7, annexin A7; ANX3, annexin A3; F, forward; R, reverse; FAM, 6-carboxy fluorescein; TAMRA, tetramethylrhodamine.
